ON THIS PAGE: You will find information about how many people are diagnosed with AML each year. You will also learn some general information on surviving the disease. Remember, survival rates depend on several factors. To see other pages, use the menu.
This year, an estimated 21,380 people of all ages (11,960 men and boys and 9,420 women and girls) in the United States will be diagnosed with AML. AML is the second most common type of leukemia diagnosed in adults and children.It is rare for the disease to occur before age 45; the average age at the time of diagnosis is 67 years.
An estimated 10,590 deaths (6,110 men and boys and 4,480 women and girls) from AML will occur this year.
The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people with AML is approximately 27%.
However, it is important to note that survival depends on several factors, including biologic features of the disease and, in particular, a patient’s age (see Subtypes for more information). Although AML is a serious disease, it is treatable and often curable with chemotherapy with or without a bone marrow/stem cell transplant (see the Treatment Options section).
It is important to remember that statistics on the survival rates for people with AML are an estimate. The estimate comes from annual data based on the number of people with this cancer in the United States. Also, experts measure the survival statistics every 5 years. So the estimate may not show the results of better diagnosis or treatment available for less than 5 years. People should talk with their doctor if they have questions about this information. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society's (ACS) publication, Cancer Facts and Figures 2016, and from the ACS website.
The next section in this guide is Medical Illustrations. It offers drawings of body parts often affected by this disease. Or, use the menu to choose another section to continue reading this guide.